SPEZIFISCHE ANTIKÖRPER GEGEN MULTIRESISTENTES (MDR) E. COLI

Patent europeic · EP2945651 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2945651
Numer da la dumonda
EP14703783
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
17-01-2014
Publitgà
25-11-2015
Concedì
07-03-2018
Stritgà
25-08-2026
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 39/395 (2006.01)
A61P 31/04 (2006.01)
C07K 16/12 (2006.01)
Prioritad
EP 13151627 17.01.2013
Dumonda PCT
PCT/EP2014/050895 17.01.2014
Publicaziun PCT
WO2014/111516 24.07.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-08-2026

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    25.08.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 25.08.2026

  2. 01-02-2025

    Next annual fee due on

    Next annual fee due on
    31.01.2025 → 31.01.2026

    Published in Swissreg on 01.02.2025

  3. 01-02-2024

    Midada

    Published in Swissreg on 01.02.2024

  4. 01-02-2023

    Midada

    Published in Swissreg on 01.02.2023

  5. 08-12-2022

    Transferì

    Owner
    X4 Pharmaceuticals (Austria) GmbH, Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria → Janssen Pharmaceuticals, Inc., 1125 Trenton-Harbourton Road, Titusville, NJ 08560, USA
    License holder
    Janssen Pharmaceuticals, Inc., 1125 Trenton-Harbourton Road, Titusville, NJ 08560, USA (allontanà)

    Published in Swissreg on 08.12.2022

  6. 27-05-2021

    Adressa midada

    Representative
    Murgitroyd & Company, 14 Rue du Rhône, 1204 Genève → Murgitroyd & Company, 4, Rue du Commerce, 1204 Genève

    Published in Swissreg on 27.05.2021

  7. 26-11-2020

    Licenza inscritta

    License holder
    Janssen Pharmaceuticals, Inc., 1125 Trenton-Harbourton Road, Titusville, NJ 08560, USA

    Published in Swissreg on 26.11.2020

  8. 18-12-2019

    Adressa midada

    Owner
    ARSANIS Biosciences GmbH, Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria → X4 Pharmaceuticals (Austria) GmbH, Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria

    Published in Swissreg on 18.12.2019

2 endataziuns pli veglias
  1. 06-06-2018

    Represchentant inscrit

    Representative
    Murgitroyd & Company, 14 Rue du Rhône, 1204 Genève

    Published in Swissreg on 06.06.2018

  2. 07-03-2018

    Concedì

    Published in Swissreg on 07.03.2018

Partidas

Possessur

Janssen Pharmaceuticals, Inc.

1125 Trenton-Harbourton Road, Titusville, NJ 08560, US

Represchentant

Murgitroyd & Company

4, Rue du Commerce, 1204 Genève

Inventur

NAGY, Eszter

1070 Wien, AT

NAGY, Gábor

9400 Sopron, HU

SZIJÁRTO, Valéria

1160 Vienna, AT

MAGYARICS, Zoltán

1110 Vienna, AT

MIRKINA, Irina

1020 Vienna, AT

GUACHALLA, Luis

1210 Vienna, AT

BADARAU, Adriana

1030 Vienna, AT

ZAUNER, Gerhild

1040 Vienna, AT

LUKASIEWICZ, Jolanta

53-201 Wroclaw, PL

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.